Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 22, 2011 - Issue 3
Submit an article Journal homepage
200
Views
2
CrossRef citations to date
0
Altmetric
Papulosquamous disease

Experience with biologics for psoriasis in daily practice: Rotational therapy is required

Clarisse SaccomaniCentre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
SéVerine PenzCentre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Raphaelle Guerre-SchmidtCentre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Fabien PelletierCentre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Eve PuzenatCentre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Marie-Odile Riou-GottaCentre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Philippe Humbert
&
François AubinCorrespondence[email protected]
 show all
Pages 151-152 | Received 14 Dec 2009, Accepted 15 Dec 2009, Published online: 05 Jun 2010

References

  • Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009; 23(suppl 2):1–70.
  • Selenko-Gebauer N, Karlhofer F, Stingl G. Efalizumab in routine use: A clinical experience. Br J Dermatol. 2007; 156(suppl 2):1–6.
  • Warren RB, Brown BC, Lavery D, Ashcroft DM, Griffiths CE. Biologic therapies for psoriasis: Practical experience in a UK tertiary referral centre. Br J Dermatol. 2009;160(1):162–169.
  • Driessen RJ, Boezeman JB, van de Kerkhof PC, de Jong EM. Three-year registry data on biological treatment for psoriasis: The influence of patient characteristics on treatment outcome. Br J Dermatol. 2009;160(3):670–675.
  • Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004;50(3):416–430.
  • Lecluse LLA, de Groot M, Bos JD, Spuls PI. Experience with biologics for psoriasis in daily practice: Switching is worth to try. Br J Dermatol. 2009;161(4):948–951.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.